Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants

NAActive, not recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

June 25, 2019

Study Completion Date

December 30, 2025

Conditions
Bronchopulmonary Dysplasia
Interventions
DIETARY_SUPPLEMENT

Cream Supplement group

Infants in the intervention arm will receive the cream supplement in addition to the standard regimen.

Trial Locations (8)

6020

University Hospital, Innsbruck

32806

Orlando Health, Inc. - Winnie Palmer Hospital for Women and Babies, Orlando

44512

Children's Hospital Medical Center of Akron, Boardman

48824

Michigan State University, East Lansing

76104

Cook Children's Medical Center, Fort Worth

77030

Baylor College of Medicine / Texas Children's Hospital, Houston

84057

Wasatch Neonatal, Orem

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

Prolacta Bioscience

INDUSTRY

collaborator

Medical University Innsbruck

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

Michigan State University

OTHER

collaborator

Akron Children's Hospital

OTHER

collaborator

Timpanogos Regional Hospital

UNKNOWN

collaborator

Orlando Health, Inc.

OTHER

collaborator

St. Louis Children's Hospital

OTHER

collaborator

Baylor Scott and White Health

OTHER

collaborator

Westchester Medical Center

OTHER

collaborator

Unity Health Toronto

OTHER

collaborator

St. John Hospital & Medical Center

OTHER

collaborator

Texas Tech University Health Sciences Center, El Paso

OTHER

collaborator

Cook Children's Medical Center

OTHER

collaborator

University of Oklahoma

OTHER

lead

Baylor College of Medicine

OTHER

NCT02475434 - Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants | Biotech Hunter | Biotech Hunter